Sepsis & Septic Shock Market in 7MM to Post 7.9% CAGR to 2026, Expects GlobalData in Its Report Published at MarketPublishers.com

15 Nov 2017 • by Natalie Aster

LONDON – Currently, generic products dominate the sepsis and septic shock market, as the management of such patients chiefly relies upon antibacterial therapy, fluid resuscitation, vasostimulants, antithrombotic agents, steroids, and immunoprotein therapy.

The competition is intense for these therapy options, and the market has reached saturation with a host of suppliers offering cheap generic drugs. The sepsis and septic shock market is poised to witness the launch of 4 novel first-in-class pipeline therapeutics (Traumakine, BMS-936559, CYT107, and recAP) and 3 improved therapeutic modalities (thrombomodulin, selepressin, and cefiderocol), and also 2 novel hemoperfusion devices such as CytoSorb and Toraymyxin.

The global sepsis and septic shock market in the 7MM is poised to expand at an astonishing CAGR of 7.9%, amounting to USD 5.9 billion in total sales by 2026.

GlobalData’s comprehensive research report “OpportunityAnalyzer: Sepsis and Septic Shock - Opportunity Analysis and Forecasts to 2026” provides an all-round analysis of the sepsis and septic shock market landscape and dynamics across the 7MM – the USA, Germany, France, Italy, the UK, Spain, and Japan.

The publication discloses information on the etiology, epidemiology, pathophysiology, as well current routine recommendations pertaining to this complex disease. It provides top-line market revenue data from 2016 plus forecasts to 2026. The study includes detailed about the recent acquisitions, approvals and recommendations of governmental organisations. The research explores the key trends shaping and propelling the world sepsis and septic shock market. It identifies the companies with the most robust pipeline, gives a comprehensive review of pipeline products and technologies. The report sheds light on the major trends, innovative technologies and products, market segments, and firms likely to affect the sepsis and septic shock market in the offing. It examines the existing and prospective competition in the world sepsis and septic shock marketplace; gives an all-encompassing review of the important drivers, restraints and challenges with respect to the industry.

Find many more research reports by GlobalData at its online page at MarketPublishers.com.

CONTACTS

The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]
MarketPublishers.com